Results 311 to 320 of about 10,851,050 (358)

Combination antiretroviral therapy

Expert Opinion on Pharmacotherapy, 2011
Combination antiretroviral therapy (cART) was one of the greatest achievements in medicine in the twentieth century. It has rapidly evolved during the last 10 years from suboptimal monotherapy to an effective triple therapy that can change the natural history of HIV-1 infection from a deadly disease to a chronic, manageable condition.
Pere, Domingo, Francesc, Vidal
openaire   +2 more sources

All‐in‐One Phototheranostics: Single Laser Triggers NIR‐II Fluorescence/Photoacoustic Imaging Guided Photothermal/Photodynamic/Chemo Combination Therapy

Advanced Functional Materials, 2019
Development of single near‐infrared (NIR) laser triggered phototheranostics for multimodal imaging guided combination therapy is highly desirable but is still a big challenge.
Qi Wang, Yeneng Dai, Jingzeng Xu, Jie Cai, Xinrui Niu, Lei Zhang, Runfeng Chen, Qingming Shen, Wei Huang, Quli Fan   +9 more
semanticscholar   +1 more source

Antihypertensive combination therapy

Drugs of Today, 1998
The rationale behind employing combination antihypertensive therapy stems from growing evidence that there is a greater need for more aggressive control of systemic arterial pressure to levels below what we have traditionally accepted (140/90 mmHg), and that we have had historically poor control rates with existing approaches to antihypertensive ...
openaire   +2 more sources

Combination therapy for combined dyslipidemia

The American Journal of Cardiology, 2002
Patients with combined dyslipidemia are at high risk for coronary artery disease and often require combination drug therapy to achieve lipid levels recommended by the US National Cholesterol Education Program's third Adult Treatment Panel (ATP III). In addition to recommendations for low-density lipoprotein (LDL) cholesterol and triglyceride levels ...
Antonios M, Xydakis, Christie M, Ballantyne   +1 more
openaire   +2 more sources

Statin–Fibrate Combination Therapy

The Annals of Pharmacotherapy, 2001
BACKGROUND: Precautionary warnings for severe myopathy and rhabdomyolysis from the coadministration of statins and fibrates have been well publicized. However, a recent cerivastatin labeling change made the combined use with fibric acid derivatives a contraindication.
A, Shek, M J, Ferrill
openaire   +2 more sources

Acitretin combination therapy

Journal of the American Academy of Dermatology, 1999
Systemic therapies used in psoriasis such as methotrexate, PUVA, cyclosporine, and acitretin often have side effects that limit their usefulness. Combination therapy, an effective strategy for treating psoriasis, allows use of lower doses of medications to achieve superior therapeutic results with fewer side effects.
openaire   +2 more sources

Combination therapy with oncolytic viruses and immune checkpoint inhibitors

Expert Opinion on Biological Therapy, 2020
Introduction: Immune checkpoint inhibitors (ICI) have dramatically improved the outcome for cancer patients across multiple tumor types. However the response rates to ICI monotherapy remain relatively low, in part due to some tumors cultivating an ...
M. Chiu, Edward Armstrong, V. Jennings, S. Foo, E. Crespo-Rodriguez, G. Bozhanova, E. Patin, M. McLaughlin, D. Mansfield, Gabriella Baker, L. Grove, M. Pedersen, J. Kyula, V. Roulstone, A. Wilkins, F. McDonald, K. Harrington, A. Melcher   +17 more
semanticscholar   +1 more source

Combination Bronchodilator Therapy

Drugs, 1982
Bronchodilators may be classified into 3 groups: anticholinergics, beta-adrenoceptor agonists and methylxanthines. These drugs act through related biochemical pathways and there are theoretical reasons for expecting beneficial additive or synergistic interactions between them.
openaire   +2 more sources

Combined Antidepressant Therapy

British Journal of Psychiatry, 1971
It is still generally believed that it is dangerous to combine the tricyclic antidepressants with any of the M.A.O. inhibitors, and the Federal Drug Administration, the Witts Committee and the drug manufacturers caution against so doing. Several current texts reiterate these warnings. (Beck, 1967; Malitz, 1966: Shepherd et al., 1968).
openaire   +2 more sources

Combination drug therapy for combined hyperlipidemia

Current Cardiology Reports, 1999
Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events. Although preliminary experience has been gained using treatment combinations of niacin with statins, and fibrates ...
openaire   +2 more sources